Literature DB >> 7671557

Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.

A Bakkali-Nadi1, F Malaisse-Lagae, W J Malaisse.   

Abstract

The insulinotropic action of meglitinide was compared to that of its analogs S 3075, A-4166, KAD-1229 and repaglinide. None of these hypoglycemic agents significantly enhanced insulin output from rat pancreatic islets incubated for 90 min in the absence of exogenous nutrient. However, all these agents, when tested at a 10 microM concentration, augmented insulin release evoked by either 7 mM D-glucose or 10 microM succinic acid monomethyl ester (SAM). In this respect, meglitinide was a less efficient secretagogue than the other non-sulfonylurea hypoglycemic agents. Moreover, in the presence of 7 mM D-glucose, the lowest concentration of the drug required to cause a significant increase in insulin output decreased from about 1.0 microM for meglitinide to 0.1 microM with A-4166, KAD-1229 or repaglinide and even close to 10 nM in the case of S 3075. The concentration-response relationship thus yielded the following hierarchy, S 3075 > KAD-1229 = repaglinide > A-4166 > meglitinide, there being a difference of more than two orders of magnitude between the weakest and most potent agent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7671557

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  6 in total

Review 1.  Regulation, perturbation, and correction of metabolic events in pancreatic islets.

Authors:  W J Malaisse
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Fate of 3H- and 14C-labelled A-4166 in pancreatic islets.

Authors:  F Malaisse-Lagae; W J Malaisse
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

Review 3.  Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.

Authors:  C R Culy; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  A review of the efficacy and safety of oral antidiabetic drugs.

Authors:  Stephanie Aleskow Stein; Elizabeth Mary Lamos; Stephen N Davis
Journal:  Expert Opin Drug Saf       Date:  2012-12-14       Impact factor: 4.250

Review 5.  Drug therapy of postprandial hyperglycaemia.

Authors:  A D Mooradian; J E Thurman
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

6.  Effect of repaglinide on insulin secretion in islets from rats infused for two days with a hypertonic solution of D-glucose.

Authors:  K Louchami; L Ladrière; H Jijakli; W J Malaisse
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.